Cargando…
Resistance related metabolic pathways for drug target identification in Mycobacterium tuberculosis
BACKGROUND: Increasing resistance to anti-tuberculosis drugs has driven the need for developing new drugs. Resources such as the tropical disease research (TDR) target database and AssessDrugTarget can help to prioritize putative drug targets. Hower, these resources do not necessarily map to metabol...
Autores principales: | Cloete, Ruben, Oppon, Ekow, Murungi, Edwin, Schubert, Wolf-Dieter, Christoffels, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745158/ https://www.ncbi.nlm.nih.gov/pubmed/26856535 http://dx.doi.org/10.1186/s12859-016-0898-8 |
Ejemplares similares
-
In silico repurposing of a Novobiocin derivative for activity against latency associated Mycobacterium tuberculosis drug target nicotinate-nucleotide adenylyl transferase (Rv2421c)
por: Cloete, Ruben, et al.
Publicado: (2021) -
Molecular modelling and simulation studies of the Mycobacterium tuberculosis multidrug efflux pump protein Rv1258c
por: Cloete, Ruben, et al.
Publicado: (2018) -
DDPC: Dragon Database of Genes associated with Prostate Cancer
por: Maqungo, Monique, et al.
Publicado: (2011) -
Metabolomic analysis of Mycobacterium tuberculosis reveals metabolic profiles for identification of drug-resistant tuberculosis
por: Chaiyachat, Pratchakan, et al.
Publicado: (2023) -
Mycobacterium tuberculosis H37Rv: In Silico Drug Targets Identification by Metabolic Pathways Analysis
por: Amir, Asad, et al.
Publicado: (2014)